AMINO-OXO-INDOLE-YLIDENE COMPOUNDS FOR USE IN TREATING SCALP SKIN ITCHING - Patent 1893173
Neu REFIX β-glucan reduces muscle fibrosis in Duchenne muscular dystrophy MDX mice, in joint research with Dr. Yoshitsugu Aoki, NCNP, Tokyo, Japan. | Business Wire
Kappa Alpha Psi Line Crossing Jacket (Krimson) – Nupemall
Dr Rhonda Patrick PQQ Brand Choice (Pyrroloquinoline Quinone)
WO2015114660A1 - Novel heterobicyclic compounds as kappa opioid agonists - Google Patents
Pyrroloquinoline Quinone Resists Denervation-Induced Skeletal Muscle Atrophy by Activating PGC-1α and Integrating Mitochondrial Electron Transport Chain Complexes | PLOS ONE
NEB mutations disrupt the super-relaxed state of myosin and remodel the muscle metabolic proteome in nemaline myopathy | Acta Neuropathologica Communications | Full Text
Our Disease Focus | Rocket Pharmaceuticals
Myotonic Dystrophy Pipeline Appears Robust With 25+ Key
AMINO-OXO-INDOLE-YLIDENE COMPOUNDS FOR USE IN TREATING SCALP SKIN ITCHING - Patent 1893173
Parent Project Muscular Dystrophy Provides $500,000 in Funding to Kinea Bio Through PPMD Venture Pathways Program to Support Next-Gen Midi-Dystrophin Gene Therapy Development
Clinical Studies – BioPQQ
Analytical evaluation of P1NP assay, a biochemical marker of bone turnover - Biochemia Medica
WO2015114660A1 - Novel heterobicyclic compounds as kappa opioid agonists - Google Patents
Natural Quinone Dyes: A Review on Structure, Extraction Techniques, Analysis and Application Potential | Waste and Biomass Valorization
Dr Rhonda Patrick PQQ Brand Choice (Pyrroloquinoline Quinone)